Navigation Links
Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain
Date:9/23/2011

result in overdose and death.Summary of Clinical StudyPatients evaluated in this randomized, double-blind, double-dummy active controlled, superiority study had moderate-to-severe low back pain for at least three months and were receiving treatment with opioid analgesics at doses between 30 to 80 mg of morphine sulfate or the equivalent at least four days per week for at least 30 days prior to the screening visit.  Sixty-two percent (62%) of patients were taking hydrocodone-containing medications; 21% were taking oxycodone-containing medications; and 12% of patients were taking propoxyphene-containing medications.  Prospective patients were excluded if they were currently using the fentanyl transdermal-system, extended-release hydromorphone, or more than 80 mg per day of oral morphine equivalent for pain control upon entry into the study.

The study employed an enriched design – allowing only patients who both tolerated and responded to Butrans during an open label run-in period to enter into the 12-week double-blind phase of the trial, mimicking the treatment of patients in a clinical practice setting.  

The efficacy and safety of Butrans 20 mcg/hour was assessed using Butrans 5 mcg/hour as the low-dose control group.  All patients wore either active or placebo patches (double-dummy technique).  The study was performed at 75 centers in the United States.

Of the 1160 patients that entered the open-label run-in period, 57% were able to titrate to and tolerate the adverse effects of Butrans 20 mcg/hour and were randomized into a 12-week double-blind treatment phase.  Twelve percent (12%) of patients discontinued due to an adverse event and 21% discontinued due to lack of a therapeutic effect during the open-label titration period. A total of 660 patients were randomized to the double-blind phase to receive Butrans 20 mcg/hour, Butrans 5 mcg/hour, or an active control, for 12 weeks.  During the double-blind t
'/>"/>

SOURCE Purdue Pharma L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AIMs Program for Improving Echocardiography Appropriateness Yields Impressive Results
2. Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results
3. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
4. Misonix Schedules Fourth Quarter and Year-End Fiscal 2011 Financial Results Conference Call; September 20, 2011 at 4:30 p.m. Eastern
5. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
6. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Results
7. Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
8. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
9. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
10. Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraColl® for the Management of Post-operative Pain and Receives "Notice of Allowability" for XaraColl U.S. Patent Application
11. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... has notified the Board of Directors of his decision to step ... as CFO of Severn Trent plc.  James will leave Shire at ... search for a new CFO immediately. Flemming Ornskov, Shire,s ... lead a high-quality finance team at Shire. We are very grateful ...
(Date:10/17/2014)... CHAPEL HILL, N.C. , Oct. 17, 2014 ... healthcare landscape, the Medical Affairs function has come ... metrics, allocating resources efficiently and managing globalization.  ... at Best Practices, LLC is dedicated to providing ... issues. The Medical Affairs Consortium is a service ...
(Date:10/17/2014)... 17, 2014 ... announced the addition of the  "China Interventional ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... China impacted by ... consumption concept, dietary habit, way of working ...
Breaking Medicine Technology:Interim Chief Financial Officer James Bowling to Step Down 2Interim Chief Financial Officer James Bowling to Step Down 3Interim Chief Financial Officer James Bowling to Step Down 4Early Key Findings from the Medical Affairs Consortium Research 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
... DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty ... global sales volumes of the Levulan® Kerastick®, an ... technology platform, surpassed one million units. , "The ... the U.S. and abroad continue to embrace Levulan ...
... ViroPharma Incorporated (Nasdaq: VPHM ) reported today its financial ... Delivered $81 million in net product sales including $29 million in ... million; GAAP net income reached $20 million; Improved working capital ... of 2009, including cash and cash equivalents of $289 million; and ...
Cached Medicine Technology:DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units 2ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 12ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 13ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 14ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 15
(Date:10/20/2014)... It’s hard to imagine what it’s like ... children around the world, it’s a reality. And while new ... are forced to walk barefoot on rocky terrain or sewage-lined ... with their friends. , Buckner International's Shoes for ... in October to encourage support for Air1 and while ...
(Date:10/20/2014)... USA (PRWEB) October 20, 2014 Do ... track interventions? Here comes a wonderful app Metassessor for ... app development company helped its client “Intervention Development ... efficiently. The app is designed for iOS 4.3 or ... touch. This app is optimized for iPhone 5. It ...
(Date:10/19/2014)... 20, 2014 Recently, BambooIndustry.com, one of ... its new range of bamboo deckings . Moreover, ... natural items; they are now available at deeply discounted ... it is hard to overstate the significance of online ... to online services. The company’s workers are striving to ...
(Date:10/19/2014)... Having been working in the garment industry for decades, LunaDress’ ... to James, one of the company’s top designers, many ladies ... skirts that add beauty to them. Chiffon floor length outfits ... its new selection of 2014 long prom dresses. , ... are available in over 20 popular designs. The company intends ...
(Date:10/19/2014)... October 20, 2014 SweetDressy.com, a professional ... announced its promotion for long evening dresses . ... the special offer; the current discount is up to ... the industry pioneers in the fashion field. Its dress ... ladies dwelling in various parts of the world. All ...
Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... Hatshepsut, Egypt's greatest female Pharaoh died in pain probably due ... study by researchers has revealed. ,The daughter ... half-brother, Hatshepsut reigned from 1498 to 1483 BC as the ... Akhenaton and Tutankhamun. ,Archaeologists led by Zahi ...
... 8.3 million by the year 2030, with 80 percent ... done to tighten trans-border controls on the trade, international ... that are encountering a major increase in the next ... epidemics," said Douglas Bettcher, director of the World Health ...
... Scotland's national drink, is on sale for 1,000 pounds a measure. ... Perthshire, the rare Johnnie Walker 1805 has just gone on sale. ... bottles have been made to celebrate the birthday of the label's ... makers claim, by the fact the majority of the nine malts ...
... Vishnugarh village in Jharkhand's Hazaribagh District after over 100 people ... those villagers, who had gone out of their village to ... the deadly virus. ,The remote village fraught ... disbelief, after 35 AIDS deaths were reported in the last ...
... some form of alcohol abuse or alcohol addiction during their ... ,Some 12.5 percent of more than 43,000 ... lives, including 3.8 percent who had had the problem during ... addition, researchers led by Deborah Hasin of Columbia University Medical ...
... health checks on their players, finds research published ... Medicine. ,The findings are based on survey ... championship), rugby (union and league), and County cricket. ... not legally obliged as employers to carry out health ...
Cached Medicine News:Health News:Pharaoh Hatshepsut Died in Pain Due to Cancer 2Health News:Annual Tobacco-related Deaths to Reach 8.3 Million by 2030 2Health News:Scot's National Drink, Now Available at 1,000 Pounds a Nip 2Health News:Jharkhand Village Shocked to Know About Its Huge HIV Positive Population 2Health News:UK Sports Clubs Failing to Run Comprehensive Health Checks on Professional Players 2
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... Hormone (FSH) is intimately involved in the ... of the gonadal tissues, which synthesize and ... The levels of circulating FSH is controlled ... feedback relationship. The FSH Quantitative Test ...
... Our Class II Direct to High Res SSP kits ... a single tray. Locus specific typing on a single ... , Straight from genomic DNA to high resolution ... Allele level typing with a single tray , Unique ...
... Res SSP kits provide high resolution typing of the ... on a single tray reduces QC and testing costs ... to high resolution results, no need for initial low ... tray , Unique reaction pattern for most common alleles ...
Medicine Products: